Karen Akinsanya's Net Worth
$5.65 Million
Who is Karen Akinsanya?
Karen Akinsanya has an estimated net worth of $5.65 Million. This is based on reported shares across multiple companies, which include Nautilus Biotechnology, Inc., and Schrodinger, Inc..
SEC CIK
Karen Akinsanya's CIK is 0001797672
Past Insider Trading and Trends
2021 was Karen Akinsanya's most active year for acquiring shares with 8 total transactions. Karen Akinsanya's most active month to acquire stocks was the month of July. 2020 was Karen Akinsanya's most active year for disposing of shares, totalling 20 transactions. Karen Akinsanya's most active month to dispose stocks was the month of July. 2021 saw Karen Akinsanya paying a total of $488,956.86 for 137,246 shares, this is the most they've acquired in one year. In 2021 Karen Akinsanya cashed out on 114,492 shares for a total of $3,602,395.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nautilus Biotechnology, Inc. (NAUT) Snapshot price: $2.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Schrodinger, Inc. (SDGR) Snapshot price: $20.5
President R&D, Therapeutics
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
$30.05 | -$71,614.13 |
0
|
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$32.74 | -$79,165.26 |
0
|
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$34.23 | -$1,775,021.94 |
0
|
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$39.86 | -$1,187,637.06 |
0
|
Scheduled
|
Jun 7 - Jun 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
$41.61 | -$1,027,086.06 |
0
|
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
$35.48 | -$217,755.11 |
0
|
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$35.22 | -$1,288,127.07 |
0
|
Scheduled
|
Aug 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||